Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.
Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.
The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable ...
In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...
One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.